{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:42:13Z","timestamp":1768315333545,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T00:00:00Z","timestamp":1430611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s40618-015-0292-9","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T06:14:36Z","timestamp":1430547276000},"page":"1175-1182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["TP53 polymorphism may contribute to genetic susceptibility to develop Hashimoto\u2019s thyroiditis"],"prefix":"10.1007","volume":"38","author":[{"given":"R. M.","family":"Ruggeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M.","family":"Vicchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Giovinazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Certo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alibrandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Trovato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,3]]},"reference":[{"key":"292_CR1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8:275\u2013283","journal-title":"Nat Rev Mol Cell Biol"},{"key":"292_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/nar\/26.1.205","volume":"21","author":"P Hainaut","year":"1998","unstructured":"Hainaut P, Hernandez T, Robinson A (1998) IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualization tools. Nucleic Acids Res 21:205\u2013213","journal-title":"Nucleic Acids Res"},{"key":"292_CR3","first-page":"a001198","volume":"6","author":"VA Belyi","year":"2010","unstructured":"Belyi VA, Ak P, Markert E (2010) The origins and evolution of the p53 family of genes. Cold Spring Harb Perspect Biol 6:a001198","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"292_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrc2584","volume":"9","author":"C Whibley","year":"2009","unstructured":"Whibley C, Pharoah PD, Hollstein M (2009) p53 polymorphisms: cancer implications. Nat Rev Cancer 9:95\u2013107","journal-title":"Nat Rev Cancer"},{"key":"292_CR5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35037728","volume":"407","author":"PH Krammer","year":"2000","unstructured":"Krammer PH (2000) CD 95\u2019s deadly mission in the immune system. Nature 407:789\u2013795","journal-title":"Nature"},{"key":"292_CR6","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1096\/fj.10-175299","volume":"25","author":"S Zhang","year":"2011","unstructured":"Zhang S, Zheng M, Kibe R (2011) Trp53 negatively regulates autoimmunity via the STAT3-Th17 axis. FASEB J 25:2387\u20132398","journal-title":"FASEB J"},{"key":"292_CR7","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.4049\/jimmunol.1300509","volume":"191","author":"H Kawashima","year":"2013","unstructured":"Kawashima H, Takatori H, Suzuki K (2013) Tumor suppressor p53 inhibits systemic autoimmune diseases by inducing regulatory T cells. J Immunol 191:3614\u201332623","journal-title":"J Immunol"},{"key":"292_CR8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.20062476","volume":"204","author":"DD Orsted","year":"2007","unstructured":"Orsted DD, Bojesen SE, Tybjaerg-Hansen A (2007) Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population. J Exp Med 204:1295\u20131301","journal-title":"J Exp Med"},{"key":"292_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2164-7-15","volume":"7","author":"XS Puente","year":"2006","unstructured":"Puente XS, Velasco G, Guti\u00e9rrez-Fern\u00e1ndez A (2006) Comparative analysis of cancer genes in the human and chimpanzee genomes. BMC Genom 7:15","journal-title":"BMC Genom"},{"key":"292_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000154324","volume":"46","author":"A Sjalander","year":"1996","unstructured":"Sjalander A, Birgander R, Saha N (1996) p53 polymorphisms and haplotypes show distinct differences between major ethnic groups. Hum Hered 46:41\u201348","journal-title":"Hum Hered"},{"key":"292_CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1093","volume":"33","author":"P Dumont","year":"2003","unstructured":"Dumont P, Leu JI, Della Pietra AC (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357\u2013365","journal-title":"Nat Genet"},{"key":"292_CR12","first-page":"1151","volume":"21","author":"C Boltze","year":"2002","unstructured":"Boltze C, Roessner O, Landt E (2002) Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma. Int J Oncol 21:1151\u20131154","journal-title":"Int J Oncol"},{"key":"292_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2004.01.016","volume":"210","author":"F Granja","year":"2004","unstructured":"Granja F, Morari J, Morari EC (2004) Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett 210:151\u2013157","journal-title":"Cancer Lett"},{"key":"292_CR14","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s13277-013-1359-x","volume":"35","author":"F Wang","year":"2014","unstructured":"Wang F, Wang P, Wang B (2014) Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk. Tumour Biol 35:2723\u20132728","journal-title":"Tumour Biol"},{"key":"292_CR15","first-page":"752","volume":"53","author":"E Felley-Bosco","year":"1993","unstructured":"Felley-Bosco E, Weston A, Cawley HM (1993) Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet 53:752\u2013759","journal-title":"Am J Hum Genet"},{"key":"292_CR16","doi-asserted-by":"crossref","first-page":"24245","DOI":"10.1074\/jbc.M414637200","volume":"280","author":"X Li","year":"2005","unstructured":"Li X, Dumont P, Della Pietra A (2005) The codon 47 polymorphism in p53 is functionally significant. J Biol Chem 280:24245\u201324251","journal-title":"J Biol Chem"},{"key":"292_CR17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.humpath.2008.09.018","volume":"40","author":"A Franchi","year":"2009","unstructured":"Franchi A, Sardi I, Cetica V (2009) Pediatric sinonasal neuroendocrine carcinoma after treatment of retinoblastoma. Hum Pathol 40:750\u2013755","journal-title":"Hum Pathol"},{"key":"292_CR18","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1056\/NEJMra021194","volume":"348","author":"EN Pearce","year":"2003","unstructured":"Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Eng J Med 348:2646\u20132655","journal-title":"N Eng J Med"},{"key":"292_CR19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF03347103","volume":"36","author":"F Aghini-Lombardi","year":"2013","unstructured":"Aghini-Lombardi F, Vitti P, Antonangeli L, Southern Italy Study Group for Iodine Deficiency Disorders (2013) The size of the community rather than its geographical location better defines the risk of iodine deficiency: results of an extensive survey in Southern Italy. J Endocrinol Invest 36:282\u2013286","journal-title":"J Endocrinol Invest"},{"key":"292_CR20","unstructured":"Kleimbaum DG, Klein M (2002) A self-learning text. Logistic regression, Springer, New York, pp 7\u201326"},{"key":"292_CR21","first-page":"243","volume":"1","author":"AP Weetman","year":"2012","unstructured":"Weetman AP (2012) The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto. Eur J Endocrinol 1:243\u2013250","journal-title":"Eur J Endocrinol"},{"key":"292_CR22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0029-1214415","volume":"41","author":"AP Weetman","year":"2009","unstructured":"Weetman AP (2009) The genetics of autoimmune thyroid disease. Horm Metabol Res 41:421\u2013425","journal-title":"Horm Metabol Res"},{"key":"292_CR23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1530\/eje.0.1500605","volume":"150","author":"MF Prummel","year":"2004","unstructured":"Prummel MF, Strieder T, Wiersinga WM (2004) The environment and autoimmune thyroid diseases. Eur J Endocrinol 150:605\u2013618","journal-title":"Eur J Endocrinol"},{"key":"292_CR24","first-page":"303","volume":"36","author":"A Guerra","year":"2013","unstructured":"Guerra A, Sapio MR, Carrano M, Di Stasi V, Volpe A, Murino A, Izzo G, Vitale M (2013) Prevalence of Dio 2(T92A) polymorphism and its association with thyroid autoimmunity. J Endocrinol Invest 36:303\u2013306","journal-title":"J Endocrinol Invest"},{"key":"292_CR25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40618-013-0036-7","volume":"37","author":"P Agretti","year":"2014","unstructured":"Agretti P, De Marco G, Di Cosmo C, Bagattini B, Ferrarini E, Montanelli L, Vitti P, Tonacchera M (2014) Frequency and effect on serum TSH of phosphodiesterase 8B (PDE8B) gene polymorphisms in patients with sporadic nonautoimmune subclinical hypothyroidism. J Endocrinol Invest 37:189\u2013194","journal-title":"J Endocrinol Invest"},{"key":"292_CR26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0002-9440(10)64356-8","volume":"160","author":"Y Yamanishi","year":"2002","unstructured":"Yamanishi Y, Boyle DL, Pinkoski MJ (2002) Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am J Pathol 160:123\u2013130","journal-title":"Am J Pathol"},{"key":"292_CR27","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2337\/diabetes.54.5.1423","volume":"54","author":"SJ Zheng","year":"2005","unstructured":"Zheng SJ, Lamhamedi-Cherradi SE, Wang P (2005) Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function. Diabetes 54:1423\u20131428","journal-title":"Diabetes"},{"key":"292_CR28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-5728(02)00428-9","volume":"135","author":"M Okuda","year":"2003","unstructured":"Okuda M, Bernard CC (2003) Regulatory role of p53 in experimental autoimmune encephalomyelitis. J Neuroimmunol 135:29\u201337","journal-title":"J Neuroimmunol"},{"key":"292_CR29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1006\/mthe.2001.0343","volume":"3","author":"Q Yao","year":"2001","unstructured":"Yao Q, Wang S, Glorioso JC (2001) Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation. Mol Ther 3:901\u2013910","journal-title":"Mol Ther"},{"key":"292_CR30","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar1448","volume":"7","author":"Y Yamanishi","year":"2005","unstructured":"Yamanishi Y, Boyle DL, Green DR (2005) p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis. Arthritis Res Ther 7:R12\u2013R18","journal-title":"Arthritis Res Ther"},{"key":"292_CR31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0961203311434941","volume":"21","author":"YH Lee","year":"2012","unstructured":"Lee YH, Bae SC, Choi SJ (2012) Associations between the p53 codon 72 polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis. Lupus 21:430\u2013437","journal-title":"Lupus"},{"key":"292_CR32","first-page":"3333","volume":"60","author":"SP Hussain","year":"2000","unstructured":"Hussain SP, Amstad P, Raja K (2000) Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 60:3333\u20133337","journal-title":"Cancer Res"},{"key":"292_CR33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1515\/JPEM.2010.23.3.291","volume":"23","author":"ML Manca Bitti","year":"2010","unstructured":"Manca Bitti ML, Saccucci P, Bottini E (2010) p53 codon 72 polymorphism and type 1 diabetes mellitus. J Pediat Endocrinol Metab 23:291\u2013292","journal-title":"J Pediat Endocrinol Metab"},{"key":"292_CR34","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1365-2265.2007.03121.x","volume":"6","author":"NE Bufalo","year":"2008","unstructured":"Bufalo NE, Santos RB, Cury AN (2008) Genetic polymorphisms associated with cigarette smoking and the risk of Graves\u2019 disease. Clin Endocrinol (Oxf) 6:982\u2013987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"292_CR35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jcla.20249","volume":"22","author":"RH Chen","year":"2008","unstructured":"Chen RH, Chang CT, Wang TY (2008) p53 codon 72 proline\/arginine polymorphism and autoimmune thyroid diseases. J Clin Lab Anal 22:321\u2013326","journal-title":"J Clin Lab Anal"},{"key":"292_CR36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1749-6632.2002.tb04253.x","volume":"966","author":"C Salmaso","year":"2002","unstructured":"Salmaso C, Bagnasco M, Pesce G (2002) Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto\u2019s thyroiditis and Graves\u2019 disease. Ann N Y Acad Sci 966:496\u2013501","journal-title":"Ann N Y Acad Sci"},{"key":"292_CR37","author":"F Trimarchi","year":"2014","unstructured":"Trimarchi F (2014) Clinical Endocrinology in the near future: a post-modern challenge. J Endocrinol Invest. doi: 10.1007\/s40618-014-0181-7","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0292-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0292-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0292-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:03:41Z","timestamp":1559502221000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0292-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,3]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0292-9","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,3]]}}}